Ligand-mediated structure changes of reconstituted P-glycoprotein.

被引：0
|
作者：
Sonveaux, N
Shapiro, AB
Vigano, C
Ruysschaert, JM
机构：
[1] Free Univ Brussels, Chim Phys Macromol Interfaces Lab, B-1050 Brussels, Belgium
[2] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada
来源：
BIOPHYSICAL JOURNAL | 1999年 / 76卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：A102 / A102
页数：1
相关论文
共 50 条
  • [21] Cisapride (CIS) is an inhibitor but not a substrate for human P-glycoprotein.
    Abdel-Rahman, SM
    Lan, L
    Yasuda, K
    Leeder, JS
    Kearns, GL
    Schuetz, EG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 97 - 97
  • [22] Grapefruit juice exerts stimulatory effects on P-glycoprotein.
    Soldner, A
    Christians, U
    Susanto, M
    Wacher, VJ
    Silverman, JA
    Benet, LZ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 205 - 205
  • [23] Ligand-mediated augmentation of KCNQ channels
    Plant, Leigh D.
    Olikara, Sonia
    Rajan, Sindhu
    Marks, Jeremy
    Goldstein, Stev A. N.
    BIOPHYSICAL JOURNAL, 2007, : 12A - 12A
  • [24] THEORY OF SEDIMENTATION FOR LIGAND-MEDIATED DIMERIZATION
    CANN, JR
    GOAD, WB
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1972, 153 (02) : 603 - 609
  • [25] A ligand-mediated dimerization mode for vancomycin
    Loll, PJ
    Miller, R
    Weeks, CM
    Axelsen, PH
    CHEMISTRY & BIOLOGY, 1998, 5 (05): : 293 - 298
  • [26] Transport of P450 (CYP) drug substrates by P-glycoprotein.
    Kim, RB
    Leake, B
    Cvetkovic, M
    Wandel, C
    Roden, MM
    Fromm, MF
    Chaudhary, AK
    Belas, F
    Roden, DM
    Wood, AJJ
    Wilkinson, GR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 206 - 206
  • [27] Identification of signal transduction components as potential therapeutic targets for circumvention of multidrug resistance mediated by P-glycoprotein.
    Yang, JM
    Vassil, AD
    Hait, WN
    CLINICAL CANCER RESEARCH, 1999, 5 : 3833S - 3833S
  • [28] Analysis of the mouse liver-specific sister P-glycoprotein.
    Lecureur, V
    Sun, D
    Schuetz, E
    Schuetz, J
    HEPATOLOGY, 1998, 28 (04) : 532A - 532A
  • [29] Frontal chromatographic analysis of drug interactions with immobilized P-glycoprotein.
    Lu, L
    Leonessa, F
    Clarke, R
    Wainer, IW
    CLINICAL CANCER RESEARCH, 1999, 5 : 3833S - 3833S
  • [30] Haloperidol, reduced haloperidol and HPP+ are not influenced by P-glycoprotein.
    Shin, JG
    Leonessa, F
    Clarke, R
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 129 - 129
12345